Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KAL1 Antikörper (Center)

Dieser Anti-KAL1 Antikörper ist ein Kaninchen Polyklonal Antikörper zur Detektion von KAL1 in WB und EIA. Geeignet für Human.
Produktnummer ABIN783480

Kurzübersicht für KAL1 Antikörper (Center) (ABIN783480)

Target

Alle KAL1 Antikörper anzeigen
KAL1 (Kallmann Syndrome 1 Sequence (KAL1))

Reaktivität

  • 29
  • 1
  • 1
Human

Wirt

  • 27
  • 2
Kaninchen

Klonalität

  • 28
  • 1
Polyklonal

Konjugat

  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KAL1 Antikörper ist unkonjugiert

Applikation

  • 22
  • 13
  • 13
  • 8
  • 3
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 15
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Center

    Spezifität

    This antibody detects Anosmin (Center).

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Aufreinigung

    Affinity chromatography

    Immunogen

    Raised against an 18 amino acid peptide near the center of human Anosmin
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    PBS containing 0.02 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
  • Target

    KAL1 (Kallmann Syndrome 1 Sequence (KAL1))

    Andere Bezeichnung

    Anosmin-1

    Hintergrund

    Mutations in Anosmin-1, an extracellular matrix-associated glycosylated protein, have been linked with Kallmann Syndrome (KS), an X-linked genetic disorder characterized by loss of smell caused by abnormal olfactory bulb development and delayed puberty caused by disrupted migration of the gonadotropin-releasing hormone neuron. Anosmin-1 has been shown to directly bind FGFR1 via its N-terminal cysteine-rich domain, whey-acidic protein-like domain, and its first FnIII repeat with the D2 and D3 ectodomains of FGFR1. It is thought that Anosmin-1 can modulate FGFR1 signaling and have opposing effects on the formation and activation of FGF2-FGFR1-heparing complex.Synonyms: ADMLX, Adhesion molecule-like X-linked, KAL, KAL1, KALIG1, Kallmann syndrome protein

    Gen-ID

    3730

    NCBI Accession

    NP_000207

    UniProt

    P23352
Sie sind hier:
Chat with us!